Adverum Biotechnologies Inc operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Adverum Biotechnologies Inc with three other
companies in this sector in the United States:
sales of $1.54 million
Eyegate Pharmaceuticals Inc
of which 100%
was Eyecare products).
Adverum Biotechnologies Inc reported sales of $1.61 million
December of 2018.
decrease of 12.8%
versus 2017, when the company's sales were $1.85 million.